1. Home
  2. CKPT vs MPX Comparison

CKPT vs MPX Comparison

Compare CKPT & MPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKPT
  • MPX
  • Stock Information
  • Founded
  • CKPT 2014
  • MPX 1965
  • Country
  • CKPT United States
  • MPX United States
  • Employees
  • CKPT N/A
  • MPX N/A
  • Industry
  • CKPT Biotechnology: Pharmaceutical Preparations
  • MPX Marine Transportation
  • Sector
  • CKPT Health Care
  • MPX Industrials
  • Exchange
  • CKPT Nasdaq
  • MPX Nasdaq
  • Market Cap
  • CKPT 335.9M
  • MPX 326.0M
  • IPO Year
  • CKPT 2017
  • MPX N/A
  • Fundamental
  • Price
  • CKPT $4.04
  • MPX $8.26
  • Analyst Decision
  • CKPT Buy
  • MPX Hold
  • Analyst Count
  • CKPT 3
  • MPX 1
  • Target Price
  • CKPT $4.33
  • MPX $8.00
  • AVG Volume (30 Days)
  • CKPT 1.7M
  • MPX 30.6K
  • Earning Date
  • CKPT 05-09-2025
  • MPX 04-24-2025
  • Dividend Yield
  • CKPT N/A
  • MPX 6.83%
  • EPS Growth
  • CKPT N/A
  • MPX N/A
  • EPS
  • CKPT N/A
  • MPX 0.50
  • Revenue
  • CKPT $41,000.00
  • MPX $236,555,000.00
  • Revenue This Year
  • CKPT $102,182.93
  • MPX $3.97
  • Revenue Next Year
  • CKPT $351.71
  • MPX $13.02
  • P/E Ratio
  • CKPT N/A
  • MPX $16.52
  • Revenue Growth
  • CKPT N/A
  • MPX N/A
  • 52 Week Low
  • CKPT $1.38
  • MPX $7.49
  • 52 Week High
  • CKPT $4.50
  • MPX $12.47
  • Technical
  • Relative Strength Index (RSI)
  • CKPT 63.60
  • MPX 49.95
  • Support Level
  • CKPT $3.94
  • MPX $7.91
  • Resistance Level
  • CKPT $4.06
  • MPX $8.35
  • Average True Range (ATR)
  • CKPT 0.05
  • MPX 0.41
  • MACD
  • CKPT -0.03
  • MPX 0.03
  • Stochastic Oscillator
  • CKPT 83.33
  • MPX 63.11

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

About MPX Marine Products Corporation

Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.

Share on Social Networks: